ZA201607415B
(en )
2019-06-26
Antibody-drug-conjugate and its use for the treatment of cancer
IL248455A0
(en )
2016-11-30
Igf-1r antibody-drug-conjugate and its use for the treatment of cancer
IL276733A
(en )
2020-09-30
Use of eribulin in the treatment of cancer
IL251630A0
(en )
2017-06-29
Combination therapy for use in cancer therapy
SMT202100115T1
(en )
2021-05-07
Combinations of fgfr- and cmet-inhibitors for the treatment of cancer
IL251371A0
(en )
2017-05-29
Cortexolone 17alpha-benzoate for use in the treatment of tumours
PT3200815T
(en )
2021-05-07
Methods and compositions for treating cancer
IL251905B
(en )
2021-03-25
Apilimod for use in the treatment of renal cancer
IL248767B
(en )
2021-08-31
Trimethoxyphenyl-benzimidazole compound for use in the treatment of cancer
IL251903A0
(en )
2017-06-29
Apilimod for use in the treatment of colorectal cancer
GB201420533D0
(en )
2014-12-31
Use of Nanomaterials in treating cancer
ZA201707024B
(en )
2019-02-27
Cancer treatment composition
GB201408297D0
(en )
2014-06-25
Treatment of cancer
SG10202001388YA
(en )
2020-04-29
Use of ureidomustine (bo-1055) in cancer treatment
IL252493A0
(en )
2017-07-31
Compounds for use in the prevention or treatment of cancer
GB201417456D0
(en )
2014-11-19
Treatment of cancer
ZA201403006B
(en )
2015-10-28
Composition for use in treatment of cancer
GB201410695D0
(en )
2014-07-30
Uses of oligouronates in cancer treatment
ZA201404780B
(en )
2015-11-25
Composition for use in treatment of diabetes
GB201409362D0
(en )
2014-07-09
Treatment of cancer
GB201405449D0
(en )
2014-05-07
Treatment of cancer
GB201405075D0
(en )
2014-05-07
Treatment of cancer
GB201418640D0
(en )
2014-12-03
Agents and methods for treatment of cancer
GB201411111D0
(en )
2014-08-06
bis-Pyridazine compounds and their use in treating cancer
GB201418272D0
(en )
2014-11-26
Composition & methods of treatment